Fatty liver acupressure points are specific locations on the body used in traditional Chinese medicine, though there is no clinical evidence that acupressure can treat or reverse fatty liver disease. Non-alcoholic fatty liver disease (NAFLD) affects approximately one in three UK adults and is managed primarily through lifestyle modification, including weight loss, increased physical activity, and dietary changes as recommended by NICE. Whilst some individuals explore acupressure as a complementary wellness practice alongside conventional care, it should never replace evidence-based medical treatment. This article examines the traditional acupressure points associated with liver health, safe application techniques, and the current evidence base, whilst emphasising the importance of proven interventions for managing fatty liver disease.

Understanding Fatty Liver Disease and Complementary Approaches

Fatty liver disease, medically termed hepatic steatosis, occurs when excess fat accumulates in liver cells. The condition exists in two primary forms: non-alcoholic fatty liver disease (NAFLD), which affects individuals who drink little or no alcohol, and alcohol-related liver disease (ARLD), directly related to excessive alcohol consumption. (You may also encounter the newer terms metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH), which are increasingly used internationally.) NAFLD has become increasingly prevalent in the UK, affecting approximately one in three adults, often associated with obesity, type 2 diabetes, and metabolic syndrome.

The liver performs over 500 vital functions, including detoxification, protein synthesis, and metabolic regulation. Fatty liver is diagnosed when more than 5% of liver cells (hepatocytes) contain fat, as determined by histology or validated imaging. Simple steatosis may progress to non-alcoholic steatohepatitis (NASH), potentially leading to fibrosis, cirrhosis, or liver failure. Early-stage fatty liver disease typically presents no symptoms, though some individuals report fatigue, discomfort in the upper right abdomen, or general malaise. It is important to note that normal liver enzyme levels do not exclude NAFLD or significant fibrosis; risk stratification and non-invasive fibrosis tests are essential.

Red-flag symptoms requiring urgent medical attention include jaundice (yellowing of the skin or eyes), vomiting blood or passing black/tarry stools, new or worsening abdominal swelling, confusion or drowsiness, or severe upper right abdominal pain. If you experience any of these symptoms, call 999 immediately or attend A&E. For other concerns, contact NHS 111 or your GP urgently.

Conventional management, as recommended by NICE (NG49), focuses on lifestyle modification including weight loss, increased physical activity, dietary changes, and management of associated conditions such as diabetes and hyperlipidaemia. Evidence suggests that weight loss of 7–10% of body weight can improve liver histology, though NICE does not specify an exact target. There are currently no licensed pharmacological treatments specifically for NAFLD in the UK, making lifestyle intervention the cornerstone of therapy. Statins are generally safe in NAFLD and should be continued when indicated for cardiovascular risk reduction. If you have NAFLD, you should aim to minimise alcohol consumption; UK Chief Medical Officers advise that to keep health risks from alcohol low, it is safest not to drink more than 14 units per week on a regular basis, with several alcohol-free days each week.

UK primary care pathway: Your GP will assess your risk of advanced fibrosis using validated scores such as the FIB-4 or NAFLD Fibrosis Score. If the score is indeterminate, an Enhanced Liver Fibrosis (ELF) blood test may be performed (NICE DG34). You will be referred to a liver specialist if you have a high-risk score (e.g., FIB-4 >2.67 in adults under 65, or ELF ≥10.51) or if there is clinical concern. Transient elastography (FibroScan) is often used in secondary care to assess liver stiffness and fat content.

Many patients explore complementary approaches alongside conventional care, including acupressure—a traditional Chinese medicine technique involving manual pressure on specific body points. Whilst acupressure should never replace evidence-based medical treatment, some individuals incorporate it as part of a holistic wellness approach. It is essential to understand both the theoretical basis and the limitations of such complementary therapies when considering them for liver health support.

Key Acupressure Points for Liver Health Support

In traditional Chinese medicine (TCM), the liver is considered responsible for the smooth flow of qi (vital energy) throughout the body. Several acupressure points are traditionally associated with liver function and overall hepatic health. It is important to emphasise that there is no clinical evidence that acupressure can treat or reverse fatty liver disease; the descriptions below reflect TCM theory, not proven physiological effects.

Liver 3 (Taichong or LV3) is perhaps the most commonly referenced point for liver health in TCM. Located on the top of the foot, in the depression between the first and second metatarsal bones (approximately two finger-widths above the webbing between the big toe and second toe), this point is traditionally believed, according to TCM theory, to promote liver qi circulation and reduce stagnation. Practitioners suggest applying firm but comfortable pressure for 1–2 minutes on each foot.

Liver 8 (Ququan or LV8) is situated on the inner side of the knee, at the end of the crease when the knee is flexed. In TCM theory, this point is associated with nourishing liver blood and supporting liver function. Gentle circular pressure may be applied while seated with the knee bent.

Liver 14 (Qimen or LV14) is traditionally considered the 'alarm point' of the liver in TCM. Because this point is located on the chest wall over the ribs and vital organs, and anatomical landmarks vary by sex, body habitus, and age, it is not recommended for self-treatment. If you wish to explore this point, consult a qualified acupressure or acupuncture practitioner.

Stomach 36 (Zusanli or ST36), found four finger-widths below the kneecap and one finger-width lateral to the shin bone, whilst not liver-specific, is considered a general wellness point in TCM. Other points sometimes referenced include Spleen 6 (Sanyinjiao) and Gallbladder 34 (Yanglingquan), which relate to digestive and metabolic processes in TCM philosophy.

These descriptions reflect traditional beliefs and have not been demonstrated to have clinical efficacy for NAFLD in rigorous trials. Acupressure should not replace evidence-based NAFLD management.

How to Apply Acupressure Safely at Home

If you choose to explore acupressure as a complementary wellness practice, safety and proper technique are paramount. Acupressure should always be gentle, comfortable, and never cause significant pain or bruising. Before beginning any new complementary therapy, discuss it with your GP or healthcare provider, particularly if you have underlying health conditions, take anticoagulant medications, have a bleeding disorder or low platelet count, have advanced liver disease, or are pregnant.

Preparation and environment: Find a quiet, comfortable space where you can relax without interruption. Wash your hands thoroughly and ensure your fingernails are trimmed to avoid skin damage. Sit or lie in a comfortable position that allows easy access to the points you wish to stimulate. Some practitioners recommend deep, slow breathing to enhance relaxation during the session.

Application technique: Locate the acupressure point using anatomical landmarks as described. Apply steady, firm pressure using the pad of your thumb or index finger—not the fingernail. The pressure should feel comfortable, perhaps with a slight ache or tingling sensation, but never sharp pain. Use small circular motions or sustained pressure for 1–2 minutes per point. You may repeat on both sides of the body where applicable (such as LV3 on both feet).

Frequency and duration: Traditional practitioners often suggest daily sessions of 10–15 minutes total, though there is no standardised protocol. Consistency may be more important than duration. Many people incorporate acupressure into existing relaxation routines, such as before bedtime or during meditation.

Important contraindications and cautions: Avoid acupressure if you have open wounds, skin infections, or inflammation at the point location. Do not apply pressure over areas of recent surgery, fractures, or severe varicose veins. Pregnant women should avoid certain points (particularly SP6 and LI4) that are traditionally contraindicated during pregnancy. If you have diabetic neuropathy, peripheral vascular disease, or reduced sensation in your feet, use only very light pressure on foot points and seek professional advice before self-treatment. If you have a bleeding disorder, thrombocytopenia, or decompensated liver disease, discuss acupressure with your clinician before attempting it, and avoid vigorous pressure. If you experience increased pain, dizziness, nausea, or any adverse effects, discontinue immediately and consult your healthcare provider.

Do not delay seeking medical assessment if your symptoms persist, worsen, or if red-flag symptoms develop (jaundice, vomiting blood, black stools, new abdominal swelling, confusion, or severe abdominal pain). Contact NHS 111, your GP urgently, or call 999 if symptoms are severe.

If you experience a suspected side effect from any medicine, vaccine, or medical device, you can report it via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or search for 'Yellow Card' in the Google Play or Apple App Store.

Evidence and Limitations of Acupressure for Fatty Liver

The scientific evidence for acupressure specifically treating or reversing fatty liver disease remains limited and inconclusive. Whilst traditional Chinese medicine has a long historical use spanning thousands of years, modern evidence-based medicine requires rigorous clinical trials to establish efficacy and safety. Currently, there are no high-quality randomised controlled trials published in peer-reviewed journals demonstrating that acupressure can reduce hepatic fat content, improve liver enzyme levels, or prevent progression of NAFLD.

Some small-scale studies have explored acupuncture (needle insertion) rather than acupressure (manual pressure) for metabolic conditions, with mixed results. A few preliminary studies suggest potential benefits for metabolic parameters such as insulin resistance or lipid profiles, but these findings require replication in larger, well-designed trials before clinical recommendations can be made. The mechanisms by which acupressure might theoretically influence liver health—such as modulating autonomic nervous system activity, reducing stress hormones, or improving circulation—remain speculative and unproven.

NICE guidance for NAFLD (NG49) does not include acupressure or acupuncture as recommended interventions. The evidence-based approach focuses on weight reduction through caloric restriction and increased physical activity, Mediterranean-style dietary patterns, management of cardiovascular risk factors, and monitoring for disease progression. UK Chief Medical Officers recommend at least 150 minutes of moderate-intensity aerobic activity per week (or 75 minutes of vigorous activity), plus muscle-strengthening activities on at least two days per week, and minimising sedentary time. Weight loss of 7–10% of body weight has been shown in clinical trials to improve liver histology and is supported by international guidance (e.g., EASL/EASD/EASO).

UK monitoring and referral pathway: In primary care, your GP will calculate a risk score such as FIB-4 (using age, liver enzymes, and platelet count) or the NAFLD Fibrosis Score. Age-adjusted thresholds are used for FIB-4: a score <1.3 suggests low risk of advanced fibrosis in adults under 65 (higher cut-offs may apply in older adults), whilst >2.67 suggests high risk. If your score is indeterminate, an Enhanced Liver Fibrosis (ELF) blood test may be performed (NICE DG34). An ELF score ≥10.51 indicates a high likelihood of advanced fibrosis and warrants referral to hepatology. Transient elastography (FibroScan) is often used in secondary care to assess liver stiffness and fat content. Your GP will arrange repeat testing at intervals determined by your risk level and local protocols. Remember that normal liver enzyme levels (ALT/AST) do not exclude NAFLD or significant fibrosis; risk scores and fibrosis tests are essential for accurate assessment.

Patients should be aware that relying solely on acupressure whilst neglecting proven interventions could allow disease progression. If you have been diagnosed with fatty liver disease, prioritise the lifestyle modifications and medical management recommended by your healthcare team. Complementary approaches like acupressure may be explored as part of stress reduction or general wellness practices, but should never substitute for evidence-based care. Always inform your GP about any complementary therapies you are using, as integrated care provides the safest approach to managing chronic liver conditions.

Further information and support:

• NICE NG49 (Non-alcoholic fatty liver disease: assessment and management): www.nice.org.uk/guidance/ng49

• NICE DG34 (ELF test for advanced liver fibrosis): www.nice.org.uk/guidance/dg34

• NHS NAFLD patient information: www.nhs.uk (search 'non-alcoholic fatty liver disease')

• British Liver Trust: www.britishlivertrust.org.uk

• UK Chief Medical Officers' alcohol guidelines: www.gov.uk/government/publications/alcohol-consumption-advice-on-low-risk-drinking

• UK Chief Medical Officers' physical activity guidelines: www.gov.uk/government/publications/physical-activity-guidelines-uk-chief-medical-officers-report

• MHRA Yellow Card scheme (report suspected side effects): yellowcard.mhra.gov.uk

Frequently Asked Questions